You are viewing an incomplete version of our website. Please click to reload the website as full version.

ILP-2 (N-Term) Peptide

Details for Product No. ABIN1382114, Supplier: Log in to see
Protein Name
  • hILP2
  • ILP-2
  • ILP2
Protein Region
N-Term
Origin
Human
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Blocked Antibody anti-ILP-2 (N-Term) antibody (ABIN1031417)
Characteristics 12 amino amino terminus of human ILP-2.
Human
Research Area Apoptosis/Necrosis
Application Notes ILP-2 peptide is used for blocking the. activity of ILP-2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Richter, Mir, Eiben, Lewis, Reffey, Frattini, Tian, Frank, Youle, Nelson, Notarangelo, Vezzoni, Fearnhead, Duckett: "Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family." in: Molecular and cellular biology, Vol. 21, Issue 13, pp. 4292-301, 2001

Hugot, Chamaillard, Zouali, Lesage, Cézard, Belaiche, Almer, Tysk, OMorain, Gassull, Binder, Finkel, Cortot, Modigliani, Laurent-Puig, Gower-Rousseau, Macry, Colombel, Sahbatou, Thomas: "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 599-603, 2001

Ogura, Bonen, Inohara, Nicolae, Chen, Ramos, Britton, Moran, Karaliuskas, Duerr, Achkar, Brant, Bayless, Kirschner, Hanauer, Nuñez, Cho: "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 603-6, 2001